Coloplast A/S   Report issue

For profit Phase 2
Founded: Fredensborg Denmark (1957)
Status: No NME R&D (1957)

Organization Overview

First Clinical Trial
2003
NCT00927316
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Coloplast A/S

Active Ingredients

Drugs in Phase 2 Trials (1)

fexofenadine (allegra) (1 trial)

Drugs in Other Trials (2)

e. coli 83972 (1 trial)

tinzaparin (Innohep) (1 trial)

Indications

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 3